NCT05113446

Brief Summary

  • Identify the degree of delirium in subjects with mild cognitive impairment and find the risk factors of delirium. Mortality, hospital stay, and medical expenses are analyzed as clinical consequences related to delirium incidence.
  • Dementia conversion rate and conversion period of subjects with mild cognitive impairment with delirium and it identifies the effect of delirium on dementia conversion.
  • Develop an AI(Artificial intelligence) algorithm for predicting dementia transition in subjects with mild cognitive impairment based on the research results of the 1st, 2nd, and 3rd years.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
163

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2021

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 17, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

November 9, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
3.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 1, 2022

Status Verified

July 1, 2022

Enrollment Period

1.3 years

First QC Date

October 17, 2021

Last Update Submit

July 28, 2022

Conditions

Keywords

deliriummild cognitive impairmentdementia

Outcome Measures

Primary Outcomes (2)

  • Delirium incidence in participants with mild cognitive impairment

    descriptive statistics

    The number of subjects evaluated as positive in the delirium assessment using S-CAM for 30 days from the 1st day of study participation is statistically calculated.

  • Dementia conversion rate and transition period in participants with mild cognitive impairment

    descriptive statistics

    The participant's dementia conversion is checked in units of 1 month, and the period until conversion to dementia is analyzed in units of 12 months for 36 months.

Secondary Outcomes (4)

  • Risk factors affecting participants' delirium

    On the first day of data collection, the characteristics of subjects are collected through medical records. After 12 months, the risk factors affecting the occurrence of delirium among the characteristics of the subject are analyzed.

  • Mortality

    It is statistically calculated in 30-day, 60-day, 12-month, 24-month, and 36-month increments.

  • hospital length of stay

    The period from hospitalization to discharge is calculated in days and analyzed in units of 12 months.

  • healthcare costs

    From the healthcare costs consumed during the hospital length of stay, the direct healthcare costs used only for treatment are calculated in won units and analyzed in units of 12 months.

Study Arms (1)

MCI(Mild Cognitive Impairment) group

* Inclusion criteria : Patients 65 years of age or older who are admitted to a LTC(long-term care) facilities, Patients diagnosed with mild cognitive impairment by doctors, Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination * Exclusion criteria : Patients unable to measure the delirium assessment tool, The Short Confusion Assessment Methods (S-CAM) (Inouye, 2014) due to severe vision and hearing problems, Patients with serious psychiatric or neurological diagnosis,Patients who died or were transferred on the day of admission, Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances

Diagnostic Test: Delirium assessment using S-CAM

Interventions

Twice a day, the rounds of nurses in shifts, 8:00 am - 10:00 am, 4:00 pm - 6:00 pm Trained research assistants assessed delirium using S-CAM

MCI(Mild Cognitive Impairment) group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients admitted to 3 long-term care (LTC) facilities

You may qualify if:

  • Patients 65 years of age or older who are admitted to a LTC
  • Patients diagnosed with mild cognitive impairment by doctors
  • Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination

You may not qualify if:

  • Patients unable to measure the delirium assessment tool, The Short Confusion Assessment Methods (S-CAM) (Inouye, 2014) due to severe vision and hearing problems
  • Patients with serious psychiatric or neurological diagnosis,Patients who expire or were transferred on the day of admission -
  • Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Yangsan Seoul long-term care (LTC) facilities

Daegu, Gyeongsangnam-do, 50572, South Korea

RECRUITING

Gunsan Chamsarang long-term care (LTC) facilities

Daegu, Jeollabuk-do, 54078, South Korea

NOT YET RECRUITING

Related Publications (1)

  • Moon KJ, Park M. Protocol for a prospective, longitudinal cohort study on the incidence of dementia after the onset of delirium in patients with mild cognitive impairment: MDDCohort (Mild Cognitive Impairment Delirium Dementia). BMC Geriatr. 2024 Nov 7;24(1):922. doi: 10.1186/s12877-024-05480-6.

MeSH Terms

Conditions

DeliriumCognitive DysfunctionDementia

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersCognition DisordersBrain DiseasesCentral Nervous System Diseases

Central Study Contacts

Kyoung ja Moon, doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 17, 2021

First Posted

November 9, 2021

Study Start

July 1, 2021

Primary Completion

October 31, 2022

Study Completion

December 31, 2025

Last Updated

August 1, 2022

Record last verified: 2022-07

Locations